{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:47:05Z","timestamp":1790660825919,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To date, there is a lack of population-based studies assessing the prevalence and severity of steatosis and metabolic-associated steatohepatitis (MASH) in Egypt. CAP is widely used as a non-invasive tool for hepatic steatosis assessment, yet its reliability in obese populations remains unclear. We aimed to examine the prevalence and risk factors for steatosis and steatohepatitis in Egyptian patients undergoing laparoscopic sleeve gastrectomy and evaluate CAP\u2019s diagnostic accuracy against liver biopsy in detecting hepatic steatosis. Methods: In this prospective cross-sectional study (2019\u20132023), 162 obese adults undergoing bariatric surgery were enrolled. CAP was performed prior to intraoperative wedge liver biopsy. Histological grading of steatosis and NAS scoring were conducted by blinded pathologists. Diagnostic accuracy of CAP was evaluated using AUROC, sensitivity, specificity, PPV, and NPV. Results: Hepatic steatosis was present in 63.6% of patients by liver biopsy. CAP overestimated steatosis in 40% of biopsy-confirmed S0 cases, misclassifying them as S3. CAP cutoff of 286 dB\/m for \u2265\u2009S1, sensitivity, specificity, PPV, and NPV were 57.7%, 65.0%, 76.3%, and 44.1%, respectively (AUROC\u2009=\u20090.577). Only 14.2% had steatohepatitis. Multivariate analysis identified albumin (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.040) and hemoglobin (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.018) as independent protective factors. Conclusion: CAP significantly overestimated steatosis severity highlighting its limited reliability in obese populations.\n                  <\/jats:p>","DOI":"10.1007\/s11695-025-08386-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:44:37Z","timestamp":1764333877000},"page":"117-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and Predictors of Hepatic Steatosis in Patients Undergoing Sleeve Gastrectomy: A Biopsy-proven Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Riham","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiel","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmy","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mehrez","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim Abdel","family":"Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Zalata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokia","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Farahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed El Emam Abou","family":"Eisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbasiony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"8386_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"7","key":"8386_CR2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, et al. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u2013e20141.","journal-title":"Gastroenterology"},{"key":"8386_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"issue":"1","key":"8386_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"8386_CR5","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal F, Kramer JR, Mapakshi S, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 2018;155(6):1828\u2013e372.","journal-title":"Gastroenterology"},{"issue":"2","key":"8386_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","volume":"149","author":"G Lassailly","year":"2015","unstructured":"Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379\u201388.","journal-title":"Gastroenterology"},{"issue":"3","key":"8386_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u201390.","journal-title":"Hepatology"},{"issue":"30","key":"8386_CR8","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25(30):6053\u201362.","journal-title":"World J Gastroenterol"},{"key":"8386_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"8386_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"8386_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801.","journal-title":"J Hepatol"},{"issue":"7","key":"8386_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003206","volume":"17","author":"T Wiggins","year":"2020","unstructured":"Wiggins T, Guidozzi N, Welbourn R, et al. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis. PLoS Med. 2020;17(7):e1003206.","journal-title":"PLoS Med"},{"key":"8386_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5023157","volume":"2020","author":"M Soresi","year":"2020","unstructured":"Soresi M, Cabibi D, Giglio RV, et al. The prevalence of NAFLD and fibrosis in bariatric surgery patients and the reliability of noninvasive diagnostic methods. BioMed Res Int. 2020;2020:5023157.","journal-title":"BioMed Res Int"},{"issue":"11","key":"8386_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3949\/ccjm.69.11.897","volume":"69","author":"PS Choban","year":"2002","unstructured":"Choban PS, Jackson B, Poplawski S, et al. Bariatric surgery for morbid obesity: why, who, when, how, where, and then what? Cleve Clin J Med. 2002;69(11):897\u2013903.","journal-title":"Cleve Clin J Med"},{"issue":"Suppl 1","key":"8386_CR15","first-page":"S1","volume":"21","author":"JI Mechanick","year":"2013","unstructured":"Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20132013 update: cosponsored by American association of clinical Endocrinologists, the obesity society, and American society for metabolic & bariatric surgery. Obes (Silver Spring). 2013;21(Suppl 1):S1\u201327.","journal-title":"Obes (Silver Spring)"},{"issue":"7","key":"8386_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/gut.2006.111302","volume":"56","author":"M Fraquelli","year":"2007","unstructured":"Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56(7):968\u201373.","journal-title":"Gut"},{"issue":"6","key":"8386_CR17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.5604\/01.3001.0012.7196","volume":"17","author":"GE Shiha","year":"2018","unstructured":"Shiha GE, El-Etreby S, Bahgat M, et al. Chronic hepatitis C patients with obesity: do we need two operators for accurate evaluation of liver stiffness? Ann Hepatol. 2018;17(6):959\u201367.","journal-title":"Ann Hepatol"},{"issue":"1","key":"8386_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","volume":"11","author":"G Shiha","year":"2017","unstructured":"Shiha G, Ibrahim A, Helmy A, et al. Asian-Pacific association for the study of the liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11(1):1\u201330.","journal-title":"Hepatol Int"},{"issue":"1","key":"8386_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"P Bedossa","year":"1994","unstructured":"Bedossa P, French METAVIR, Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20(1):15\u201320.","journal-title":"Hepatology"},{"issue":"6","key":"8386_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"key":"8386_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101547","volume":"51","author":"YT Cao","year":"2022","unstructured":"Cao YT, Xiang LL, Qi F, et al. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. EClinicalMedicine. 2022;51:101547.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"8386_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/liv.15127","volume":"42","author":"F Tavaglione","year":"2022","unstructured":"Tavaglione F, De Vincentis A, Bruni V, et al. Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery. Liver Int. 2022;42(2):374\u201383.","journal-title":"Liver Int"},{"issue":"3","key":"8386_CR23","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s00330-020-07245-2","volume":"31","author":"JH Runge","year":"2021","unstructured":"Runge JH, van Giessen J, Draijer LG, et al. Accuracy of controlled Attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity. Eur Radiol. 2021;31(3):1588\u201396.","journal-title":"Eur Radiol"},{"issue":"7","key":"8386_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220178","volume":"43","author":"DT Fetzer","year":"2023","unstructured":"Fetzer DT, Pierce TT, Robbin ML, et al. US quantification of liver fat: past, present, and future. Radiographics. 2023;43(7):e220178.","journal-title":"Radiographics"},{"issue":"1","key":"8386_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94970-3","volume":"11","author":"S Kimura","year":"2021","unstructured":"Kimura S, Tanaka K, Oeda S, et al. Effect of skin-capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease. Sci Rep. 2021;11(1):15641.","journal-title":"Sci Rep"},{"issue":"6","key":"8386_CR26","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"4","key":"8386_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s44320-024-00024-x","volume":"20","author":"C Sommerauer","year":"2024","unstructured":"Sommerauer C, Gallardo-Dodd CJ, Savva C, et al. Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis. Mol Syst Biol. 2024;20(4):374\u2013402.","journal-title":"Mol Syst Biol"},{"issue":"11","key":"8386_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112590","volume":"12","author":"G Sebastiani","year":"2022","unstructured":"Sebastiani G, Paisible N, Costiniuk C, et al. The relationship between visceral adiposity and nonalcoholic fatty liver disease diagnosed by controlled attenuation parameter in people with HIV: a pilot study. Diagnostics. 2022;12(11):2590.","journal-title":"Diagnostics"},{"issue":"1","key":"8386_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.soard.2017.09.527","volume":"14","author":"KP Souto","year":"2018","unstructured":"Souto KP, Meinhardt NG, Ramos MJ, et al. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Surg Obes Relat Dis. 2018;14(1):66\u201373.","journal-title":"Surg Obes Relat Dis"},{"issue":"9","key":"8386_CR30","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1136\/gutjnl-2016-312238","volume":"66","author":"P Bedossa","year":"2017","unstructured":"Bedossa P, Tordjman J, Aron-Wisnewsky J, et al. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. Gut. 2017;66(9):1688\u201396.","journal-title":"Gut"},{"issue":"11","key":"8386_CR31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1586\/17474124.2015.1092382","volume":"9","author":"SM Walenbergh","year":"2015","unstructured":"Walenbergh SM, Shiri-Sverdlov R. Cholesterol is a significant risk factor for non-alcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol. 2015;9(11):1343\u20136.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"8386_CR32","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.soard.2017.07.032","volume":"13","author":"S Barbois","year":"2017","unstructured":"Barbois S, Arvieux C, Leroy V, et al. Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. Surg Obes Relat Dis. 2017;13(10):1780\u20136.","journal-title":"Surg Obes Relat Dis"},{"issue":"9","key":"8386_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092060","volume":"15","author":"A Abdollahi","year":"2023","unstructured":"Abdollahi A, Narayanan SK, Frankovich A, et al. Albumin deficiency reduces hepatic steatosis and improves glucose metabolism in a mouse model of diet-induced obesity. Nutrients. 2023;15(9):2060.","journal-title":"Nutrients"},{"issue":"4","key":"8386_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.5604\/01.3001.0012.0920","volume":"17","author":"E Ju\u00e1rez-Hern\u00e1ndez","year":"2018","unstructured":"Ju\u00e1rez-Hern\u00e1ndez E, Ch\u00e1vez-Tapia NC, Brizuela-Alc\u00e1ntara D, et al. Association between serum hemoglobin levels and non-alcoholic fatty liver disease in a Mexican population. Ann Hepatol. 2018;17(4):577\u201384.","journal-title":"Ann Hepatol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08386-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:04:19Z","timestamp":1769609059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08386-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8386"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08386-3","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for written informed consent was waived by the ethics committee as this was an analysis of anonymized patient data collected during routine clinical care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"This study used anonymized data and does not include any identifiable individual information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}